AMREP Corporation
NYSE:AXRReal Estate - Development
-$0.34 today
- Market cap
- $106.71M
- Beta
- 1.13
- P/E (TTM)
- 10.2
- EPS (TTM)
- $2.42
Volume 0.00M
Average 0.01M
AXR Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
AMREP CorporationNYSE: AXR
Research & Development · Q3 FY2025 · quarter ended Jan 2026
Research & development remains negative
Q3 FY2025 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2024, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2024 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2024
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2024 | 2025-04-30 | 0 | — |
| FY2023 | 2024-04-30 | 0 | -100.0% |
| FY2022 | 2023-04-30 | 0 | -57.1% |
| FY2021 | 2022-04-30 | 0 | +46.1% |
| FY2020 | 2021-04-30 | 0 | — |
Research & Development vs competitors
How AXR compares with its peers on the latest reported figures
- AXR's LTM Jan 2026 research & development of $0 is the 2nd highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for AXR, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $11.11M | -48.3% | +20.6% | 1027.5% | |
| LTM Jan 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
STHOStar Holdings | LTM Mar 2026 | $0 | — | — | 0.0% |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
LPALogistic Properties of the Americas | LTM Mar 2026 | $0 | — | — | 0.0% |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding AXR) | $0 | -48.3% | +20.6% | 0.0% | |
Competitors are the stored peer set for AXR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2020 Apr 2021 | FY2021 Apr 2022 | FY2022 Apr 2023 | FY2023 Apr 2024 | FY2024 Apr 2025 |
|---|---|---|---|---|---|
| Revenue | 40.07M | 62.48M | 48.68M | 51.37M | 49.69M |
| Cost of Revenue | 25.6M | 35.82M | 29.78M | 36.9M | 16.81M |
| Gross Profit | 14.47M | 26.66M | 18.9M | 14.47M | 32.88M |
| Gross Margin | 36.1% | 42.7% | 38.8% | 28.2% | 66.2% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 5.42M | 5.35M | 13.07M | 6.87M | 7.28M |
| Operating Expenses | 5.42M | 5.35M | 13.07M | 6.87M | 20.78M |
| Depreciation & Amortization | 31.02M | 37.62M | 35.25M | 149K | 179K |
| EBITDA | 40.07M | 21.53M | 5.89M | 7.75M | 12.29M |
| EBITDA Margin | 100.0% | 34.5% | 12.1% | 15.1% | 24.7% |
| Operating Income | 9.05M | 21.3M | 5.83M | 7.6M | 12.11M |
| Operating Margin | 22.6% | 34.1% | 12.0% | 14.8% | 24.4% |
| Interest Income | 0 | 2K | 8K | 823K | 1.62M |
| Interest Expense | 40K | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 988K | 263K | 1.81M | 823K | 1.62M |
| Income Before Tax | 10.04M | 21.57M | 7.64M | 8.43M | 13.73M |
| Pre-Tax Margin | 25.0% | 34.5% | 15.7% | 16.4% | 27.6% |
| Income Tax Expense | 2.64M | 5.7M | (14.15M) | 1.74M | 1.01M |
| Net Income | 7.39M | 15.86M | 21.79M | 6.69M | 12.72M |
| Net Margin | 18.4% | 25.4% | 44.8% | 13.0% | 25.6% |
| EPS (Basic) | 0.95 | 2.21 | 4.13 | 1.26 | 2.39 |
| EPS (Diluted) | 0.95 | 2.21 | 4.11 | 1.25 | 2.37 |
| Weighted Avg Shares | 7.74M | 7.17M | 5.28M | 5.3M | 5.32M |
| Weighted Avg Shares (Diluted) | 7.77M | 7.19M | 5.31M | 5.35M | 5.37M |
AMREP Corporation
NYSE:AXR
Intrinsic Alpha fair value
Locked
Current Price
$20.04
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.